The Vita Coco Company, Inc. (COCO) 10-Q 1 Aug 24 2024 Q2 Quarterly report Financial data

Cover

Cover - shares	6 Months Ended
	Jun. 30, 2024	Jul. 30, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2024
Document Transition Report	false
Entity File Number	001-40950
Entity Registrant Name	The Vita Coco Company, Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	11-3713156
Entity Address, Address Line One	250 Park Avenue South
Entity Address, Address Line Two	Seventh Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10003
City Area Code	212
Local Phone Number	206-0763
Title of 12(b) Security	Common Stock, Par Value $0.01 Per Share
Trading Symbol	COCO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		56,782,291
Entity Central Index Key	0001482981
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 150,103	$ 132,537
Accounts receivable, net of allowance of $2,992 at June 30, 2024, and $2,486 at December 31, 2023	78,891	50,086
Inventory	45,457	50,757
Supplier advances, current	1,381	1,521
Derivative assets	140	3,876
Prepaid expenses and other current assets	24,651	24,160
Total current assets	300,623	262,937
Property and equipment, net	2,231	2,136
Goodwill	7,791	7,791
Supplier advances, long-term	2,907	2,820
Deferred tax assets, net	6,745	6,749
Right-of-use assets, net	897	1,406
Other assets	1,842	1,843
Total assets	323,036	285,682
Current liabilities:
Accounts payable	20,651	21,826
Accrued expenses and other current liabilities	64,188	59,533
Notes payable, current	10	13
Derivative liabilities	5,965	1,213
Total current liabilities	90,814	82,585
Notes payable, long-term	8	13
Other long-term liabilities	208	647
Total liabilities	91,030	83,245
Commitments and contingencies
Stockholders’ equity:
Common stock, $0.01 par value; 500,000,000 shares authorized; 63,403,113 and 63,135,453 shares issued at June 30, 2024 and December 31, 2023, respectively 56,775,369 and 56,899,253 shares outstanding at June 30, 2024 and December 31, 2023, respectively	634	631
Additional paid-in capital	166,863	161,414
Retained earnings	134,073	100,742
Accumulated other comprehensive loss	(628)	(649)
Treasury stock, 6,627,744 shares at cost as of June 30, 2024, and $6,236,200 shares at cost as of December 31, 2023.	(68,936)	(59,701)
Total stockholders’ equity attributable to The Vita Coco Company, Inc.	232,006	202,437
Total liabilities and stockholders’ equity	$ 323,036	$ 285,682

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 2,992	$ 2,486
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	63,403,113	63,135,453
Common stock, shares outstanding (in shares)	56,775,369	56,899,253
Treasury stock (in shares)	6,627,744	6,236,200

Condensed Consolidated Statemen

Condensed Consolidated Statement of Operations (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Income Statement [Abstract]
Net sales	$ 144,116	$ 139,645	$ 255,814	$ 249,404
Cost of goods sold	85,379	88,551	149,900	164,649
Gross profit	58,737	51,094	105,914	84,755
Operating expenses
Selling, general and administrative	28,756	30,249	56,974	57,206
Income (loss) from operations	29,981	20,845	48,940	27,549
Other income (expense)
Unrealized gain/(loss) on derivative instruments	(5,963)	988	(8,488)	2,201
Foreign currency gain/(loss)	(136)	170	(78)	781
Interest income	1,627	268	3,150	281
Interest expense	0	(15)	0	(30)
Total other income (expense)	(4,472)	1,411	(5,416)	3,233
Income before income taxes	25,509	22,256	43,524	30,782
Income tax expense	(6,416)	(4,269)	(10,193)	(6,090)
Net income attributable to The Vita Coco Company, Inc.	$ 19,093	$ 17,987	$ 33,331	$ 24,692
Net income per common share
Basic (in dollars per share)	$ 0.34	$ 0.32	$ 0.59	$ 0.44
Diluted (in dollars per share)	$ 0.32	$ 0.31	$ 0.57	$ 0.42
Weighted-average number of common shares outstanding
Basic (in shares)	56,705,220	56,325,013	56,647,393	56,186,727
Diluted (in shares)	59,235,211	58,854,063	58,990,921	58,103,502

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Statement of Comprehensive Income [Abstract]
Net income	$ 19,093	$ 17,987	$ 33,331	$ 24,692
Other comprehensive income (loss):
Foreign currency translation adjustment	33	(64)	21	109
Total comprehensive income attributable to The Vita Coco Company, Inc.	$ 19,126	$ 17,923	$ 33,352	$ 24,801

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Total Shareholders’ Equity Attributable to The Vita Coco Company, Inc.	Total Shareholders’ Equity Attributable to The Vita Coco Company, Inc. Impact of ASC 326 adoption	Common Stock	Additional Paid-in Capital	Retained Earnings	Retained Earnings Impact of ASC 326 adoption	Accumulated Other Comprehensive Income / (Loss)	Treasury Stock	Common Stock Common Stock	Common Stock with Exit Warrants Common Stock
Beginning balance, common stock (in shares) at Dec. 31, 2022				62,225,250						54,112,145	8,113,105
Beginning balance at Dec. 31, 2022		$ 141,093		$ 622	$ 145,210	$ 55,183		$ (994)	$ (58,928)	$ 541	$ 81
Beginning balance (Accounting Standards Update 2016-13) at Dec. 31, 2022			$ (1,070)				$ (1,070)
Beginning balance, treasury stock (in shares) at Dec. 31, 2022									6,206,200
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		6,705				6,705
Stock-based compensation		2,162			2,162
Exercise of stock awards (in shares)				185,783						185,783
Exercise of stock awards		603		$ 2	601					$ 2
Foreign currency translation adjustment		173						173
Ending balance, common stock (in shares) at Mar. 31, 2023				62,411,033						54,297,928	8,113,105
Ending balance at Mar. 31, 2023		149,666		$ 624	147,973	60,818		(821)	$ (58,928)	$ 543	$ 81
Ending balance, treasury stock (in shares) at Mar. 31, 2023									6,206,200
Beginning balance, common stock (in shares) at Dec. 31, 2022				62,225,250						54,112,145	8,113,105
Beginning balance at Dec. 31, 2022		141,093		$ 622	145,210	55,183		(994)	$ (58,928)	$ 541	$ 81
Beginning balance (Accounting Standards Update 2016-13) at Dec. 31, 2022			$ (1,070)				$ (1,070)
Beginning balance, treasury stock (in shares) at Dec. 31, 2022									6,206,200
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 24,692
Ending balance, common stock (in shares) at Jun. 30, 2023				62,641,890						54,528,785	8,113,105
Ending balance at Jun. 30, 2023		171,805		$ 626	152,187	78,805		(885)	$ (58,928)	$ 545	$ 81
Ending balance, treasury stock (in shares) at Jun. 30, 2023									6,206,200
Beginning balance, common stock (in shares) at Mar. 31, 2023				62,411,033						54,297,928	8,113,105
Beginning balance at Mar. 31, 2023		149,666		$ 624	147,973	60,818		(821)	$ (58,928)	$ 543	$ 81
Beginning balance, treasury stock (in shares) at Mar. 31, 2023									6,206,200
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 17,987	17,987				17,987
Stock-based compensation		2,102			2,102
Exercise of stock awards (in shares)				230,857						230,857
Exercise of stock awards		2,114		$ 2	2,112					$ 2
Foreign currency translation adjustment		(64)						(64)
Ending balance, common stock (in shares) at Jun. 30, 2023				62,641,890						54,528,785	8,113,105
Ending balance at Jun. 30, 2023		171,805		$ 626	152,187	78,805		(885)	$ (58,928)	$ 545	$ 81
Ending balance, treasury stock (in shares) at Jun. 30, 2023									6,206,200
Beginning balance, common stock (in shares) at Dec. 31, 2023	56,899,253			63,135,453						55,022,348	8,113,105
Beginning balance at Dec. 31, 2023	$ 202,437	202,437		$ 631	161,414	100,742		(649)	$ (59,701)	$ 550	$ 81
Beginning balance, treasury stock (in shares) at Dec. 31, 2023	6,236,200								6,236,200
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income		14,238				14,238
Purchase of treasury stock (in shares)									391,544
Purchase of treasury stock		(9,235)							$ (9,235)
Stock-based compensation		2,109			2,109
Exercise of stock awards (in shares)				176,284						176,284
Exercise of stock awards		153		$ 2	151					$ 2
Foreign currency translation adjustment		(12)						(12)
Ending balance, common stock (in shares) at Mar. 31, 2024				63,311,737						55,198,632	8,113,105
Ending balance at Mar. 31, 2024		209,690		$ 633	163,674	114,980		(661)	$ (68,936)	$ 552	$ 81
Ending balance, treasury stock (in shares) at Mar. 31, 2024									6,627,744
Beginning balance, common stock (in shares) at Dec. 31, 2023	56,899,253			63,135,453						55,022,348	8,113,105
Beginning balance at Dec. 31, 2023	$ 202,437	202,437		$ 631	161,414	100,742		(649)	$ (59,701)	$ 550	$ 81
Beginning balance, treasury stock (in shares) at Dec. 31, 2023	6,236,200								6,236,200
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 33,331
Ending balance, common stock (in shares) at Jun. 30, 2024	56,775,369			63,403,113						55,290,008	8,113,105
Ending balance at Jun. 30, 2024	$ 232,006	232,006		$ 634	166,863	134,073		(628)	$ (68,936)	$ 553	$ 81
Ending balance, treasury stock (in shares) at Jun. 30, 2024	6,627,744								6,627,744
Beginning balance, common stock (in shares) at Mar. 31, 2024				63,311,737						55,198,632	8,113,105
Beginning balance at Mar. 31, 2024		209,690		$ 633	163,674	114,980		(661)	$ (68,936)	$ 552	$ 81
Beginning balance, treasury stock (in shares) at Mar. 31, 2024									6,627,744
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 19,093	19,093				19,093
Stock-based compensation		2,399			2,399
Exercise of stock awards (in shares)				91,376						91,376
Exercise of stock awards		791		$ 1	790					$ 1
Foreign currency translation adjustment		33						33
Ending balance, common stock (in shares) at Jun. 30, 2024	56,775,369			63,403,113						55,290,008	8,113,105
Ending balance at Jun. 30, 2024	$ 232,006	$ 232,006		$ 634	$ 166,863	$ 134,073		$ (628)	$ (68,936)	$ 553	$ 81
Ending balance, treasury stock (in shares) at Jun. 30, 2024	6,627,744								6,627,744

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended		12 Months Ended
		Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net income		$ 19,093	$ 17,987	$ 33,331	$ 24,692
Adjustments required to reconcile net income to cash flows from operating activities:
Depreciation and amortization				344	340
(Gain)/loss on disposal of equipment				13	(1)
Bad debt expense				(204)	177
Unrealized (gain)/loss on derivative instruments		5,963	(988)	8,488	(2,201)
Stock-based compensation				4,508	4,264
Noncash lease expense				508	561
Changes in operating assets and liabilities:
Accounts receivable				(28,761)	(46,605)
Inventory				5,254	27,253
Prepaid expenses, net supplier advances, and other assets				(204)	2,769
Accounts payable, accrued expenses, and other liabilities				3,375	14,822
Net cash provided by (used in) operating activities				26,652	26,071
Cash flows from investing activities:
Cash paid for property and equipment				(414)	(487)
Proceeds from sale of property and equipment				0	5
Net cash used in investing activities				(414)	(482)
Cash flows from financing activities:
Proceeds from exercise of stock awards				681	2,717
Cash received (paid) on notes payable				(8)	(12)
Cash paid to acquire treasury stock				(9,235)	0	$ (773)
Net cash provided by (used in) financing activities				(8,562)	2,705
Effects of exchange rate changes on cash and cash equivalents				(106)	371
Net increase/(decrease) in cash and cash equivalents				17,570	28,665
Cash, cash equivalents and restricted cash at beginning of the period	[1]			132,867	19,629	19,629
Cash, cash equivalents and restricted cash at end of period	[1]	$ 150,437	$ 48,294	$ 150,437	$ 48,294	$ 132,867
[1] Includes $334 and $326 of restricted cash as of June 30, 2024 and 2023, respectively, that were included in other current assets.

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows (Unaudited) (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Statement of Cash Flows [Abstract]
Restricted cash	$ 334	$ 326

Nature of Business and Basis of

Nature of Business and Basis of Presentation	6 Months Ended
	Jun. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business and Basis of Presentation	NATURE OF BUSINESS AND BASIS OF PRESENTATION The Vita Coco Company, Inc. and subsidiaries (the “Company”) develops, markets, and distributes various coconut water products under the brand name Vita Coco and for retailers' own brands, predominantly in the United States. Other products include coconut milk, coconut oil, coconut as a commodity, water (under the brand name Ever & Ever ), and protein infused fitness drinks (under the brand name PWR LIFT ). We also offered a natural energy drink (under the brand name Runa ), which we ceased selling in December 2023. The Company was incorporated in Delaware as All Market Inc. on January 17, 2007. On September 9, 2021, we changed our name to The Vita Coco Company, Inc. In 2018, the Company purchased certain assets and liabilities of Runa , which was marketed and distributed primarily in the United States until the Company ceased selling the brand in December 2023. We are a public benefit corporation under Section 362 of the Delaware General Corporation Law. As a public benefit corporation, our Board of Directors is required by the Delaware General Corporation Law to manage or direct our business and affairs in a manner that balances the pecuniary interests of our stockholders, the best interests of those materially affected by our conduct and the specific public benefits identified in our certificate of incorporation. The Company has ten wholly-owned subsidiaries including four wholly-owned Asian subsidiaries established between fiscal 2012 and 2015, four North American subsidiaries established between 2012 and 2018, All Market Europe, Ltd. (“AME”) in the United Kingdom, and one subsidiary in Germany established during 2024. Unaudited interim financial information The Company’s condensed consolidated interim financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and Article 10 of Regulation S-X. As permitted under those rules, certain footnotes or other financial information that are normally required by U.S. GAAP can be condensed or omitted. In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the Company’s financial information for the interim period presented. These interim results are not necessarily indicative of the results to be expected for the year ending December 31, 2024 or for any other interim period or for any other future year. The condensed consolidated balance sheet as of June 30, 2024 is unaudited and should be read in conjunction with the audited consolidated financial statements and the related notes thereto for the fiscal year ended December 31, 2023.

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying condensed consolidated financial statements are presented in accordance with U.S. GAAP. Principles of Consolidation The condensed consolidated financial statements include all the accounts of the wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates Preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management considers many factors in selecting appropriate financial accounting policies and controls in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. Additionally, uncertainty in the macroeconomic environment resulting from current geopolitical and economic instability (including the effects of current wars and other international conflicts) and the high interest rate and inflationary cost environment make estimates and assumptions difficult to calculate with precision. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the condensed consolidated financial statements relate to share-based compensation, assessing long-lived assets for impairment, estimating the net realizable value of inventories, determining the accounts receivables reserve, assessing goodwill for impairment, determining the value of trade promotions, and assessing the realizability of deferred income taxes. Actual results could differ from those estimates. Concentration of Credit Risk The Company’s cash and accounts receivable are subject to concentrations of credit risk. The Company’s cash balances are primarily on deposit with banks in the U.S. which are guaranteed by the Federal Deposit Insurance Corporation ("FDIC") up to $250. At times, such cash may be in excess of the FDIC insurance limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality institutions, which may include banks, financial institutions and investment firms, and invest daily or reserve operating cash in money market funds, government securities, bank obligations, municipal securities or other investment vehicles with short-term maturities. Substantially all of the Company’s customers are either wholesalers or retailers of beverages. A material default in payment, a material reduction in purchases from these or any large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company’s financial condition, results of operations and liquidity. The Company is exposed to concentration of credit risk from its major customers for which two customers in aggregate represented 49% and 53% of total net sales for the six months ended June 30, 2024 and 2023, respectively. In addition, the two customers in aggregate also accounted for 45% and 43% of total accounts receivable as of June 30, 2024 and December 31, 2023, respectively. The Company has not experienced credit issues with these customers. Refer to Note 7, Commitments and Contingencies regarding additional information on our major customers. Recently Adopted Accounting Pronouncements In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). The new accounting standard introduced the current expected credit losses methodology ("CECL") for estimating allowances for credit losses. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized costs, including loans and trade receivables. ASU 2016-13 was effective for the Company for annual and interim reporting periods beginning after December 15, 2022. The Company adopted the standard on January 1, 2023 using the modified retrospective method for all financial assets in scope. As a part of the adoption, the Company selected to apply roll-rate method to estimate current expected credit losses for its accounts receivable population and weighted average remaining maturity ("WARM") method for supplier advances. The difference of $1,070 between the incurred credit loss estimate and current expected credit loss estimate was recorded as cumulative effect adjustment to the Company’s opening retained earnings and reflected on the consolidated balance sheet as of January 1, 2023 as a result of the ASC Topic 326, Financial Instruments - Credit Losses ("ASC 326") adoption. The adoption of the standard did not have a material impact on the Company’s consolidated statements of operations, or consolidated statements of cash flows. The following table illustrates the impact of ASC 326. As of January 1, 2023 As reported under ASC 326 Pre-ASC 326 adoption Impact of ASC 326 adoption Allowance for credit losses on accounts receivables $ 3,552 $ 2,898 $ 654 Allowance for credit losses on supplier advances 416 — 416 Total $ 3,968 $ 2,898 $ 1,070

Revenue Recognition

Revenue Recognition	6 Months Ended
	Jun. 30, 2024
Revenue from Contract with Customer [Abstract]
Revenue Recognition	REVENUE RECOGNITION Revenues are accounted for in accordance with ASC Topic 606, Revenue Recognition ("ASC 606"). The Company disaggregates revenue into the following product categories: • Vita Coco Coconut Water —This product category consists of all branded coconut water product offerings under the Vita Coco labels, where the majority ingredient is coconut water. The Company determined that the sale of the products represents a distinct performance obligation as customers can benefit from purchasing the products on their own or together with other resources that are readily available to the customers. For these products, control is transferred upon customer receipt, at which point the Company recognizes the transaction price for the product as revenue. • Private Label —This product category consists of all private label product offerings, which includes coconut water and oil. The Company determined the production and distribution of private label products represents a distinct performance obligation. Since there is no alternative use for these products and the Company has the right to payment for performance completed to date, the Company recognizes the revenue for the production of these private label products over time as the production for open purchase orders occurs, which may be prior to any shipment. • Other —This product category consists of all other products, which included Runa (until we ceased selling it in December 2023), and includes Ever & Ever and PWR LIFT product offerings and Vita Coco product extensions beyond coconut water, coconut milk products, and other revenue transactions (e.g., bulk product sales). For these products, control is transferred upon customer receipt, at which point the Company recognizes the transaction price for the product as revenue. The Company excludes from revenues all taxes assessed by a governmental authority that are imposed on the sale of its products and collected from customers. The Company provides trade promotions and sales discounts to its customers and distributors. Since these sales promotions and sales discounts do not meet the criteria for a distinct good or service, they are primarily accounted for as a reduction of revenue and include payments to customers and distributors for performing activities on our behalf, such as payments for in-store displays, payments to gain distribution of new products, payments for shelf space and discounts to promote lower retail prices. These condensed consolidated financial statements include accruals for these promotion and discounts. The accruals are made for invoices that have not yet been received as of the end of the reporting period and are recorded as a reduction of sales, and are based on contract terms and our historical experience with similar programs and require management judgment with respect to estimating customer and consumer participation and performance levels. Disaggregation of Revenue The following table disaggregates net revenue by product type and reportable segment: Three Months Ended June 30, 2024 Americas International Consolidated Vita Coco Coconut Water $ 98,494 $ 13,952 $ 112,446 Private Label 23,135 4,816 27,951 Other 2,873 846 3,719 Total $ 124,502 $ 19,614 $ 144,116 Three Months Ended June 30, 2023 Americas International Consolidated Vita Coco Coconut Water $ 95,004 $ 12,720 $ 107,724 Private Label 24,059 5,053 29,112 Other 2,200 609 2,809 Total $ 121,263 $ 18,382 $ 139,645 Six Months Ended June 30, 2024 Americas International Consolidated Vita Coco Coconut Water $ 168,016 $ 23,617 $ 191,633 Private Label 47,408 9,968 57,376 Other 5,169 1,636 6,805 Total $ 220,593 $ 35,221 $ 255,814 Six Months Ended June 30, 2023 Americas International Consolidated Vita Coco Coconut Water $ 164,142 $ 22,278 $ 186,420 Private Label 49,109 7,719 56,828 Other 4,784 1,372 6,156 Total $ 218,035 $ 31,369 $ 249,404

Inventory

Inventory	6 Months Ended
	Jun. 30, 2024
Inventory Disclosure [Abstract]
Inventory	INVENTORY Inventory consists of the following: June 30, December 31, Raw materials and packaging $ 3,130 $ 3,360 Finished goods 42,327 47,397 Inventory $ 45,457 $ 50,757

Goodwill

Goodwill	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	GOODWILL Goodwill consists of the following: June 30, December 31, Goodwill $ 7,791 $ 7,791

Debt

Debt	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Debt	DEBT The table below details the outstanding balances on the Company’s debt as of June 30, 2024 and December 31, 2023: June 30, December 31, Notes payable Vehicle loans 18 26 $ 18 $ 26 Current 10 13 Non-current $ 8 13 Revolving Credit Facility In May 2020, the Company entered into the five-year credit facility with Wells Fargo Bank, National Association consisting of a revolving line of credit, which currently provides for committed borrowings of $60 million (the "2020 Credit Facility"). The maturity date on the 2020 Credit Facility is May 12, 2026. Starting in December 2022, borrowings on the 2020 Credit Facility bear interest at rates based on either: 1) a fluctuating rate per annum determined to be the sum of Daily Simple Secured Overnight Financing Rate ("SOFR") plus a spread defined in the credit agreement (the "Spread"); or 2) a fixed rate per annum determined to be the sum of the Term SOFR plus the Spread. The Spread ranges from 1.00% to 1.75%, which is based on the Company’s leverage ratio (as defined in the credit agreement) for the immediately preceding fiscal quarter as defined in the credit agreement. In addition, the Company is currently subject to an unused commitment fee ranging from 0.10% and 0.20% on the unused amount of the line of credit, with the rate being based on the Company’s leverage ratio (as defined in the credit agreement). As of June 30, 2024 and December 31, 2023, the Company had no outstanding balance and $60 million undrawn and available under its amended 2020 Credit Facility. The Company incurred no interest expense for the 2020 Credit Facility for the six months ended June 30, 2024 and June 30, 2023, respectively. The unused commitment fee for the 2020 Credit Facility amounted to $15 and $15 for the three months ended June 30, 2024 and June 30, 2023, respectively. The unused commitment fee for the 2020 Credit Facility amounted to $30 and $30 for the six months ended June 30, 2024 and June 30, 2023, respectively. The 2020 Credit Facility is collateralized by substantially all of the Company’s assets. The 2020 Credit Facility contains certain affirmative and negative covenants that, among other things, limit the Company’s ability to, subject to various exceptions and qualifications: (i) incur liens; (ii) incur additional debt; (iii) sell, transfer or dispose of assets; (iv) merge with or acquire other companies, (v) make loans, advances or guarantees; (vi) make investments; (vii) make dividends and distributions on, or repurchases of, equity; and (viii) enter into certain transactions with affiliates. The 2020 Credit Facility also requires the Company to maintain certain financial covenants including a maximum leverage ratio, a minimum fixed charge coverage ratio, and a minimum asset coverage ratio. As of June 30, 2024, the Company was in compliance with all financial covenants. Vehicle Loans

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES Contingencies: Litigation —The Company may engage in various litigation matters in the ordinary course of business. The Company intends to vigorously defend itself in such matters, based upon the advice of legal counsel, and is of the opinion that the resolution of these matters will not have a material effect on the condensed consolidated financial statements.The Company records a liability when it is probable that a loss has been incurred and the amount is reasonably estimable. The Company also discloses when it is reasonably possible that a material loss may be incurred. As of June 30, 2024 and December 31, 2023, the Company has not recorded any liabilities relating to such legal matters. Business Risk —The Company imports finished goods predominantly from manufacturers located in South American and Southeast Asian countries. The Company may be subject to certain business risks due to potential instability in these regions. Major Customers —The Company’s customers that accounted for 10% or more of total net sales and total accounts receivable were as follows: Net sales Accounts receivable Six Months Ended June 30, June 30, December 31, 2024 2023 Customer A 27 % 30 % 25 % 20 % Customer B 22 % 23 % 20 % 23 % One of the customers acquired less than 5% ownership in the Company upon consummation of the Company's initial public offering ("IPO"). As discussed in Note 10, Stockholders' Equity , the same customer also was granted 200,000 restricted stock awards at the time of the IPO, of which 100,000 vested on March 31, 2023 and 100,000 vested on March 31, 2024. The customer continues to hold less than 5% ownership in the Company as of June 30, 2024. In 2023, we agreed to start to discontinue the private label coconut water and coconut oil supply relationship with one of our significant customers as the terms required to retain the business were contrary to our long term margin targets. However, at the request of this customer, we have continued the supply relationship for a significant portion of their private label coconut water needs. Major Suppliers —The Company’s suppliers that accounted for 10% or more of the Company’s purchases were as follows: Six Months Ended June 30, 2024 2023 Supplier A 22 % 20 % Supplier B 14 % 15 %

Derivative Instruments

Derivative Instruments	6 Months Ended
	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	DERIVATIVE INSTRUMENTS The Company accounts for derivative instruments in accordance with the ASC Topic 815, Derivatives and Hedging ("ASC 815"). These principles require that all derivative instruments be recognized at fair value on each balance sheet date unless they qualify for a scope exclusion as a normal purchase or sales transaction, which is accounted for under the accrual method of accounting. In addition, these principles permit derivative instruments that qualify for hedge accounting to reflect the changes in the fair value of the derivative instruments through earnings or stockholders’ equity as other comprehensive income on a net basis until the hedged item is settled and recognized in earnings, depending on whether the derivative is being used to hedge changes in fair value or cash flows. The ineffective portion of a derivative instrument’s change in fair value is immediately recognized in earnings. As of June 30, 2024 and December 31, 2023, the Company did not have any derivative instruments that it had designated as fair value or cash flow hedges. The Company is subject to the following currency risks: Inventory Purchases from Brazilian, Malaysian and Thai Manufacturers —In order to mitigate the currency risk on inventory purchases from its Brazilian, Malaysian and Thai manufacturers, which are settled in Brazilian real ("BRL"), Malaysian ringgit ("MYR") and Thai baht ("THB"), the Company's subsidiary, All Market Singapore Pte. Ltd. ("AMS"), enters a series of forward currency swaps to buy BRL, MYR and THB. Intercompany Transactions Between AME and AMS —In order to mitigate the currency risk on intercompany transactions between AME and AMS, AMS enters into foreign currency swaps to sell British pounds ("GBP"). Intercompany Transactions with Canadian Customer and Vendors —In order to mitigate the currency risk on transactions with Canadian customer and vendors, the Company enters into foreign currency swaps to sell Canadian dollars ("CAD"). The notional amount and fair value of all outstanding derivative instruments in the condensed consolidated balance sheets consist of the following at: June 30, 2024 Derivatives not designated as Notional Fair Balance Sheet Location Assets Foreign currency exchange contracts Receive USD/pay EUR $ 4,279 $ 55 Derivative assets Receive USD/pay CAD 6,097 85 Derivative assets Liabilities Foreign currency exchange contracts Receive BRL/sell USD $ 51,459 $ (4,339) Derivative liabilities Receive THB/sell USD 18,647 (1,243) Derivative liabilities Receive USD/pay GBP 21,277 (383) Derivative liabilities December 31, 2023 Derivatives not designated as Notional Fair Balance Sheet Location Assets Foreign currency exchange contracts Receive BRL/sell USD $ 62,253 $ 3,876 Derivative assets Liabilities Foreign currency exchange contracts Receive THB/sell USD 21,971 (285) Derivative liabilities Receive USD/pay EUR 5,627 (90) Derivative liabilities Receive USD/pay GBP 23,512 (749) Derivative liabilities Receive USD/pay CAD 7,666 (89) Derivative liabilities The amount and location of realized and unrealized gains and losses of the derivative instruments in the condensed consolidated statements of operations for the three and six months ended June 30, 2024 and 2023 are as follows: Three Months Ended June 30, 2024 2023 Unrealized gain/(loss) on derivative instruments $ (5,963) $ 988 Location Unrealized gain/(loss) Unrealized gain/(loss) Foreign currency gain / (loss) $ 188 $ 1,572 Location Foreign currency Foreign currency Six Months Ended June 30, 2024 2023 Unrealized gain/(loss) on derivative instruments $ (8,488) $ 2,201 Location Unrealized gain/(loss) Unrealized gain/(loss) Foreign currency gain / (loss) $ 795 $ 2,643 Location Foreign currency Foreign currency The Company applies recurring fair value measurements to its derivative instruments in accordance with ASC Topic 820, Fair Value Measurements ("ASC 820"). In determining fair value, the Company used a market approach and incorporated the assumptions that market participants would use in pricing the asset or liability, including assumptions about risk and/or the risks inherent in the inputs to the valuation technique. These inputs can be readily observable, market corroborated or generally unobservable internally developed inputs.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	FAIR VALUE MEASUREMENTS ASC 820 provides a framework for measuring fair value and requires expanded disclosures regarding fair value measurements. ASC 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs. Based upon observability of the inputs used in valuation techniques, the Company’s assets and liabilities are classified as follows: Level 1 —Quoted market prices in active markets for identical assets or liabilities. Level 2 —Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted market prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 —Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes internally developed models and methodologies utilizing significant unobservable inputs. Forward Currency Swap Contracts —See Note 8, Derivative Instruments , for a description of these contracts. The Company’s valuation methodology for forward currency swap contracts is based upon third-party institution data. The Company’s fair value hierarchy for those assets (liabilities) measured at fair value on a recurring basis at June 30, 2024 and December 31, 2023, is as follows: Level 1 Level 2 Level 3 Total Forward Currency June 30, 2024 $ — $ (5,825) $ — $ (5,825) December 31, 2023 $ — $ 2,663 $ — $ 2,663 There were no transfers between any levels of the fair value hierarchy for any of the Company’s fair value measurements.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2024
Equity [Abstract]
Stockholders' Equity	STOCKHOLDERS’ EQUITY Common and Treasury Stock —Each share of Common Stock entitles its holder to one vote on matters required to be voted on by the stockholders of the Company and to receive dividends, when and if declared by the Company’s Board of Directors. As of June 30, 2024 and December 31, 2023, the Company held 6,627,744 and 6,236,200 shares, respectively, in treasury stock. As of June 30, 2024 and December 31, 2023, the Company had 3,219,779 and 3,124,326 shares, respectively, of Common Stock available for issuance upon the conversion of outstanding equity awards under the 2021 Incentive Award Plan ("2021 Plan"). On October 30, 2023, the Company's Board of Directors approved a share repurchase program ("Program") authorizing the Company to repurchase up to $40,000 of Common Stock. Shares of Common Stock may be repurchased under the Program from time to time through open market purchases, block trades, private transactions or accelerated or other structured share repurchase programs. To the extent not retired, shares of Common Stock repurchased under the Program will be placed in the Company's treasury shares. The extent to which the Company repurchases shares of Common Stock, and the timing of such repurchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other corporate considerations, as determined by the Company. The Program has no time limits and may be suspended or discontinued at any time. The Company repurchased no shares under this Program during the three months ended June 30, 2024. The Company repurchased 391,544 shares under this Program at a cost of $9,235 during the six months ended June 30, 2024. The Company repurchased 30,000 shares under this Program at a cost of $773 during the year ended December 31, 2023. As of June 30, 2024, the Company had $29,992 remaining under this Program. On May 23, 2023, the Company entered into an underwriting agreement (the "Underwriting Agreement") with BofA Securities, Inc., Evercore Group L.L.C. and Goldman Sachs & Co. LLC, as the representative of the underwriters named in Schedule I thereto (collectively, the "Underwriters"), and a stockholder of the Company, Verlinvest Beverages SA (the "Selling Stockholder"), relating to an underwritten public offering of 5,000,000 shares (the "Offering") of Common Stock at a price to the public of $23.00 per share, before deducting underwriting discounts. Pursuant to the Underwriting Agreement, all 5,000,000 shares of Common Stock were sold by the Selling Stockholder. Under the terms of the Underwriting Agreement, the Selling Stockholder granted the Underwriters an option exercisable for 30 days to purchase up to an additional 750,000 shares of Common Stock from the Selling Stockholder at the public offering price, less underwriting discounts and commissions, which option was exercised in full prior to the closing of the Offering. The closing of the Offering occurred on May 26, 2023. The Company did not receive any of the proceeds from the sale of the shares. Additionally, the Company incurred $856 of administrative expenses related to the Offering, which were expensed in the six months ended June 30, 2023. Stock-based Compensation —The stockholders of the Company approved the adoption of the Company’s 2014 Stock Option and Restricted Stock Plan (the “2014 Plan”). The 2014 Plan allowed for a maximum of 8% of the sum of the Available Equity defined as the sum of: (i) the total then outstanding shares of common shares; and (ii) all available stock options (i.e., granted and outstanding stock options and stock options not yet granted). Under the terms of the 2014 Plan, the Company may grant employees, directors and consultants stock options and restricted stock awards and has the authority to establish the specific terms of each award, including exercise price, expiration and vesting. Currently, only stock options were granted under the 2014 Plan. Generally, stock options issued pursuant to the 2014 Plan contain exercise prices no less than the fair value of Common Stock on the date of grant and have a ten-year contractual term. Subsequent to September 30, 2021, the stockholders of the Company approved the adoption of the 2021 Plan, which became effective after the closing of the Company's IPO completed in October 2021. On and after closing of the offering and the effectiveness of the 2021 Plan, no further grants have been made under the 2014 Plan. The maximum number of shares of our Common Stock available for issuance under the 2021 Plan is equal to the sum of: (i) 3,431,312 shares of our Common Stock; and (ii) an annual increase on the first day of each year beginning in 2022 and ending in and including 2031, equal to the lesser of (A) two percent (2%) of the outstanding shares of our Common Stock on the last day of the immediately preceding fiscal year; and (B) such lesser amount as determined by our Board of Directors; provided, however, no more than 3,431,312 shares may be issued upon the exercise of incentive stock options ("ISOs"). The 2021 Plan provides for the grant of stock options, including ISOs and nonqualified stock options ("NSOs"), restricted stock, dividend equivalents, stock payments, restricted stock units ("RSUs"), other incentive awards, stock appreciation rights ("SARs"), and cash awards. As of June 30, 2024, only stock options, restricted stock, and RSU's have been granted under the 2021 Plan. The Company recognized stock-based compensation expense of $2,399 and $1,951 for the three months ended June 30, 2024 and 2023, respectively, in selling, general and administrative expenses. Additionally, the stock compensation expense of $4,357 and $3,248 was recognized for the six months ended June 30, 2024 and 2023, respectively, in selling, general and administrative expenses. For the RSUs previously granted to a major customer, $0 and $151 was recognized for the three months ended June 30, 2024 and June 30, 2023, respectively, as stock-based sales incentive based on guidance in ASC 606 and reflected as a reduction in the transaction price revenue. The Company recognized $151 and $1,016 for the six months ended June 30, 2024 and 2023, respectively, as a reduction in transaction price revenue for this major customer. Option Awards with Service-based Vesting Conditions Most of the stock option awards granted under the 2014 Plan and 2021 Plan vest based on continuous service. The options awarded to the employees have differing vesting schedules as specified in each grant agreement. There were 168,076 new service-based stock option awards granted during the six months ended June 30, 2024. Exercises of stock options during the three months ended June 30, 2024, and 2023 were 72,588 and 202,467, respectively. Exercises of stock options during the six months ended June 30, 2024, and 2023 were 86,548 and 268,990, respectively. Option Awards with Performance and Market-based Vesting Conditions There are also outstanding stock option awards containing performance-based vesting conditions, subject to achievement of various performance goals by a future period, such as revenue and adjusted EBITDA targets. There were also stock option awards granted in 2019 to the current Chief Executive Officer ("CEO") containing performance and market vesting conditions vesting upon occurrence of an IPO or other qualifying liquidity event and upon achieving a predetermined equity value of the Company, which fully vested as of July 31, 2023. There were no new stock option awards granted during the six months ended June 30, 2024 with performance-based vesting conditions. Service & Performance based Restricted Stock and RSUs Restricted stock and RSUs were granted under the 2021 Plan and primarily vest based on continuous service. The RSUs with service-based vesting conditions awarded to the employees have differing vesting schedules as specified in each grant agreement. The RSUs granted to non-employee directors vest in full on the earlier of: (i) the day immediately preceding the date of the first Annual Shareholders Meeting following the date of grant; or (ii) the first anniversary of the date of grant. During the six months ended June 30, 2024 and June 30, 2023, the Company also granted RSUs that contain performance-based vesting conditions, subject to achievement of various performance goals in the future, specifically net sales growth and Adjusted EBITDA targets. Also included in these awards are shares of restricted Common Stock valued at $3,000 granted at the time of the IPO to entities affiliated with a significant customer, at a price per share granted at the IPO of $15.00, or 200,000 restricted shares, in connection with an amendment to extend the distributor agreement term to June 10, 2026. Since the distribution agreement had not been terminated by either party for cause as of March 31, 2023, 50% of the shares were released on March 31, 2023. The remaining 50% were released on March 31, 2024. The grant was accounted for as a stock-based sales incentive based on guidance in ASC 606 and is reflected as a reduction in the transaction price of revenue on the basis of the grant-date fair-value measure in accordance with the stock compensation guidance in ASC 718. During the six months ended June 30, 2024, there were 259,221 service based and 58,365 performance based RSUs granted, which had an aggregate grant date fair value of $8,348. During the three months ended June 30, 2024 and June 30, 2023, awards vested were 18,788 and 28,390, respectively. During the six months ended June 30, 2024 and June 30, 2023, awards vested were 181,112 and 147,649, respectively, which includes service based RSUs and restricted stock of the major customer.

Income Taxes

Income Taxes	6 Months Ended
	Jun. 30, 2024
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES For the three months ended June 30, 2024 and 2023, the Company recorded income tax expense of $6,416 and $4,269, respectively, in its condensed consolidated statements of operations. For the six months ended June 30, 2024 and 2023, the Company recorded $10,193 and $6,090, respectively, in income tax expense in its condensed consolidated statements of operations. In assessing the recoverability of its deferred tax assets, the Company continually evaluates all available positive and negative evidence to assess the amount of deferred tax assets for which it is more likely than not to realize a benefit. For any deferred tax asset in excess of the amount for which it is more likely than not that the Company will realize a benefit, the Company establishes a valuation allowance. As of June 30, 2024 and December 31, 2023, there was a $106 liability for income tax uncertainties recorded in the Company's consolidated balance sheets. The Company’s policy is to record interest and penalties related to income taxes as part of its income tax provision. The Company does not expect its uncertain tax positions to change significantly over the next twelve months. The Company recognized no interest and penalties related to income tax uncertainties in its consolidated balance sheets or consolidated statement of operations for the three and six months ended June 30, 2024 and 2023. The Company is subject to income tax examinations by the Internal Revenue Service ("IRS") and various state and local jurisdictions for the open tax years between December 31, 2019 and December 31, 2022.

Earnings Per Share

Earnings Per Share	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Earnings Per Share	EARNINGS PER SHARE Basic and diluted earnings per share were calculated as follows: Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Numerator: Net income $ 19,093 $ 17,987 $ 33,331 $ 24,692 Denominator: Weighted-average number of common shares used in earnings per share—basic 56,705,220 56,325,013 56,647,393 56,186,727 Effect of conversion of stock options 2,529,991 2,529,050 2,343,528 1,916,775 Weighted-average number of common shares used in earnings per share—diluted 59,235,211 58,854,063 58,990,921 58,103,502 Earnings per share—basic $ 0.34 $ 0.32 $ 0.59 $ 0.44 Earnings per share—diluted $ 0.32 $ 0.31 $ 0.57 $ 0.42 The following potentially dilutive securities, prior to the use of the treasury stock method, have been excluded from the computation of diluted weighted-average number of common shares outstanding, as they would be anti-dilutive: Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Options to purchase common stock and RSUs 207,168 54,008 254,490 560,721

Segment Reporting

Segment Reporting	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Segment Reporting	SEGMENT REPORTING The Company has two operating and reportable segments: • Americas—The Americas segment is comprised primarily of the U.S. and Canada, and derives its revenues from the marketing and distribution of various coconut water and non-coconut water products (e.g., coconut oil and milk). The Company’s aluminum bottle canned water ( Ever & Ever ) and protein infused fitness drink ( PWR LIFT ) are marketed only in the Americas segment. The Company also offered guayusa leaf products ( Runa) in the Americas segment. As of December 2023, we ceased offering the Runa brand. • International—The International segment is comprised primarily of Europe, Middle East, and Asia Pacific, which includes the Company’s procurement arm and derives its revenues from the marketing and distribution of various coconut water and non-coconut water products. The Company’s CEO is the chief operating decision maker and evaluates segment performance primarily based on net sales and gross profit. All intercompany transactions between the segments have been eliminated. Information about the Company’s operations by operating segment as of the three and six months ended June 30, 2024 and 2023 is as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Net sales $ 144,116 $ 139,645 $ 255,814 $ 249,404 Americas 124,502 121,263 220,593 218,035 International 19,614 18,382 35,221 31,369 Gross profit $ 58,737 $ 51,094 $ 105,914 $ 84,755 Americas 52,208 45,109 93,080 74,258 International 6,529 5,985 12,834 10,497 As of June 30, As of December 31, 2024 2023 Total segment assets $ 323,036 $ 285,682 Americas 225,790 209,984 International 97,246 75,698 Three Months Ended June 30, Six Months Ended June 30, Reconciliation 2024 2023 2024 2023 Total gross profit $ 58,737 $ 51,094 $ 105,914 $ 84,755 Less: Selling, general, and administrative expenses 28,756 30,249 56,974 57,206 Income (loss) from operations $ 29,981 $ 20,845 $ 48,940 $ 27,549 Less: Unrealized gain/(loss) on derivative instruments (5,963) 988 (8,488) 2,201 Foreign currency gain/(loss) (136) 170 (78) 781 Interest income 1,627 268 3,150 281 Interest expense — (15) — (30) Income before income taxes $ 25,509 $ 22,256 $ 43,524 $ 30,782 Geographic Data: The following table provides information related to the Company’s net sales by country, which is presented on the basis of the location that revenue from customers is recorded: Six Months Ended June 30, 2024 2023 United States $ 205,561 $ 204,152 United Kingdom 25,862 21,622 All other countries(1) 24,391 23,631 Net sales $ 255,814 $ 249,404 ___________ (1) No individual country is greater than 10% of total net sales for the six months ended June 30, 2024 and 2023. The following table provides information related to the Company’s property and equipment, net by country: June 30, December 31, United States $ 857 $ 729 Singapore 1,076 1,081 All other countries(1) 298 326 Property and equipment, net $ 2,231 $ 2,136 ___________ (1) No individual country is greater than 10% of total property and equipment, net as of June 30, 2024 and December 31, 2023.

Related-Party Transactions

Related-Party Transactions	6 Months Ended
	Jun. 30, 2024
Related Party Transactions [Abstract]
Related-Party Transactions	RELATED-PARTY TRANSACTIONS Director Nominee Agreements - A member of the Board of Directors appointed under the Investor Rights Agreement by Verlinvest Beverages SA ("Verlinvest"), a stockholder of the Company, entered into a nominee agreement on May 24, 2022 instructing the Company to pay all cash and equity compensation earned in connection with his board of director service to Verlinvest. Based on the aforementioned nominee agreement, RSUs granted to this director will be held by him as nominee for Verlinvest and, upon vesting of the RSUs, the shares will be transferred to Verlinvest. The nominee agreements are primarily between the director and Verlinvest. The Company is a party to this arrangement solely to agree to the manner in which it would satisfy the compensation obligations to this director. Registration Rights and Underwriting Agreements

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Pay vs Performance Disclosure
Net income	$ 19,093	$ 17,987	$ 33,331	$ 24,692

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	6 Months Ended
	Jun. 30, 2024 shares	Jun. 30, 2024 shares
Trading Arrangements, by Individual
Non-Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Terminated	false
Michael Kirban Revocable Trust [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		In accordance with the disclosure requirements set forth in Item 408(a) of Regulation S-K, the following table discloses any officer (as defined in Rule 16a-1(f) under the Exchange Act), director, or entity controlled by such officer or director who adopted or terminated a contract, instruction, or written plan for the sale of securities of the Company intended to satisfy the affirmative defense of Rule 10b5-1(c) during the quarterly period ended June 30, 2024: Name Title Action Taken Date of Action Duration of Trading Arrangement Aggregate Number of Securities to be Sold The Michael Kirban Revocable Trust A trust controlled by Michael Kirban (Co-Founder, Executive Chairman and Chairman of the Board) Termination May 17, 2024 September 14, 2023 to September 13, 2024 Up to 240,000 shares of Common Stock The Ira Liran 2012 Family Trust A trust controlled by Ira Liran Adoption June 14, 2024 September 14, 2024 to September 18, 2025 Up to 250,000 shares of Common Stock
Name	The Michael Kirban Revocable Trust
Title	A trust controlled by Michael Kirban (Co-Founder, Executive Chairman and Chairman of the Board)
Rule 10b5-1 Arrangement Terminated	true
Termination Date	May 17, 2024
Arrangement Duration	365 days
Aggregate Available	240,000	240,000
Ira Liran 2012 Family Trust [Member]
Trading Arrangements, by Individual
Material Terms of Trading Arrangement		In accordance with the disclosure requirements set forth in Item 408(a) of Regulation S-K, the following table discloses any officer (as defined in Rule 16a-1(f) under the Exchange Act), director, or entity controlled by such officer or director who adopted or terminated a contract, instruction, or written plan for the sale of securities of the Company intended to satisfy the affirmative defense of Rule 10b5-1(c) during the quarterly period ended June 30, 2024: Name Title Action Taken Date of Action Duration of Trading Arrangement Aggregate Number of Securities to be Sold The Michael Kirban Revocable Trust A trust controlled by Michael Kirban (Co-Founder, Executive Chairman and Chairman of the Board) Termination May 17, 2024 September 14, 2023 to September 13, 2024 Up to 240,000 shares of Common Stock The Ira Liran 2012 Family Trust A trust controlled by Ira Liran Adoption June 14, 2024 September 14, 2024 to September 18, 2025 Up to 250,000 shares of Common Stock
Name	The Ira Liran 2012 Family Trust
Title	A trust controlled by Ira Liran
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	June 14, 2024
Arrangement Duration	369 days
Aggregate Available	250,000	250,000

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying condensed consolidated financial statements are presented in accordance with U.S. GAAP.
Principles of Consolidation	Principles of Consolidation
Use of Estimates	Use of Estimates Preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Management considers many factors in selecting appropriate financial accounting policies and controls in developing the estimates and assumptions that are used in the preparation of these condensed consolidated financial statements. Management must apply significant judgment in this process. In addition, other factors may affect estimates, including expected business and operational changes, sensitivity and volatility associated with the assumptions used in developing estimates, and whether historical trends are expected to be representative of future trends. Additionally, uncertainty in the macroeconomic environment resulting from current geopolitical and economic instability (including the effects of current wars and other international conflicts) and the high interest rate and inflationary cost environment make estimates and assumptions difficult to calculate with precision. The estimation process often may yield a range of reasonable estimates of the ultimate future outcomes, and management must select an amount that falls within that range of reasonable estimates. The most significant estimates in the condensed consolidated financial statements relate to share-based compensation, assessing long-lived assets for impairment, estimating the net realizable value of inventories, determining the accounts receivables reserve, assessing goodwill for impairment, determining the value of trade promotions, and assessing the realizability of deferred income taxes. Actual results could differ from those estimates.
Concentration of Credit Risk	Concentration of Credit Risk The Company’s cash and accounts receivable are subject to concentrations of credit risk. The Company’s cash balances are primarily on deposit with banks in the U.S. which are guaranteed by the Federal Deposit Insurance Corporation ("FDIC") up to $250. At times, such cash may be in excess of the FDIC insurance limit. To minimize the risk, the Company’s policy is to maintain cash balances with high quality institutions, which may include banks, financial institutions and investment firms, and invest daily or reserve operating cash in money market funds, government securities, bank obligations, municipal securities or other investment vehicles with short-term maturities. Substantially all of the Company’s customers are either wholesalers or retailers of beverages. A material default in payment, a material reduction in purchases from these or any large customers, or the loss of a large customer or customer groups could have a material adverse impact on the Company’s financial condition, results of operations and liquidity. The Company is exposed to concentration of credit risk from its major customers for which two customers in aggregate represented 49% and 53% of total net sales for the six months ended June 30, 2024 and 2023, respectively. In addition, the two customers in aggregate also accounted for 45% and 43% of total accounts receivable as of June 30, 2024 and December 31, 2023, respectively. The Company has not experienced credit issues with these customers. Refer to Note 7, Commitments and Contingencies
Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements	Recently Adopted Accounting Pronouncements In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). The new accounting standard introduced the current expected credit losses methodology ("CECL") for estimating allowances for credit losses. The measurement of expected credit losses under the CECL methodology is applicable to financial assets measured at amortized costs, including loans and trade receivables. ASU 2016-13 was effective for the Company for annual and interim reporting periods beginning after December 15, 2022. The Company adopted the standard on January 1, 2023 using the modified retrospective method for all financial assets in scope. As a part of the adoption, the Company selected to apply roll-rate method to estimate current expected credit losses for its accounts receivable population and weighted average remaining maturity ("WARM") method for supplier advances. The difference of $1,070 between the incurred credit loss estimate and current expected credit loss estimate was recorded as cumulative effect adjustment to the Company’s opening retained earnings and reflected on the consolidated balance sheet as of January 1, 2023 as a result of the ASC Topic 326, Financial Instruments - Credit Losses ("ASC 326") adoption. The adoption of the standard did not have a material impact on the Company’s consolidated statements of operations, or consolidated statements of cash flows. The following table illustrates the impact of ASC 326. As of January 1, 2023 As reported under ASC 326 Pre-ASC 326 adoption Impact of ASC 326 adoption Allowance for credit losses on accounts receivables $ 3,552 $ 2,898 $ 654 Allowance for credit losses on supplier advances 416 — 416 Total $ 3,968 $ 2,898 $ 1,070 Recently Issued Accounting Pronouncements In November 2023, the FASB issued Accounting Standards Update 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis ("ASU 2023-07"). Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC Topic 280, Segment Reporting on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the effective tax rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction ("ASU 2023-09"). ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-09.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2024
Accounting Policies [Abstract]
Accounts Receivable, Allowance for Credit Loss	The following table illustrates the impact of ASC 326. As of January 1, 2023 As reported under ASC 326 Pre-ASC 326 adoption Impact of ASC 326 adoption Allowance for credit losses on accounts receivables $ 3,552 $ 2,898 $ 654 Allowance for credit losses on supplier advances 416 — 416 Total $ 3,968 $ 2,898 $ 1,070

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jun. 30, 2024
Revenue from Contract with Customer [Abstract]
Summary of Disaggregation of Revenue	The following table disaggregates net revenue by product type and reportable segment: Three Months Ended June 30, 2024 Americas International Consolidated Vita Coco Coconut Water $ 98,494 $ 13,952 $ 112,446 Private Label 23,135 4,816 27,951 Other 2,873 846 3,719 Total $ 124,502 $ 19,614 $ 144,116 Three Months Ended June 30, 2023 Americas International Consolidated Vita Coco Coconut Water $ 95,004 $ 12,720 $ 107,724 Private Label 24,059 5,053 29,112 Other 2,200 609 2,809 Total $ 121,263 $ 18,382 $ 139,645 Six Months Ended June 30, 2024 Americas International Consolidated Vita Coco Coconut Water $ 168,016 $ 23,617 $ 191,633 Private Label 47,408 9,968 57,376 Other 5,169 1,636 6,805 Total $ 220,593 $ 35,221 $ 255,814 Six Months Ended June 30, 2023 Americas International Consolidated Vita Coco Coconut Water $ 164,142 $ 22,278 $ 186,420 Private Label 49,109 7,719 56,828 Other 4,784 1,372 6,156 Total $ 218,035 $ 31,369 $ 249,404

Inventory (Tables)

Inventory (Tables)	6 Months Ended
	Jun. 30, 2024
Inventory Disclosure [Abstract]
Summary of Inventory	Inventory consists of the following: June 30, December 31, Raw materials and packaging $ 3,130 $ 3,360 Finished goods 42,327 47,397 Inventory $ 45,457 $ 50,757

Goodwill (Tables)

Goodwill (Tables)	6 Months Ended
	Jun. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Goodwill	Goodwill consists of the following: June 30, December 31, Goodwill $ 7,791 $ 7,791

Debt (Tables)

Debt (Tables)	6 Months Ended
	Jun. 30, 2024
Debt Disclosure [Abstract]
Summary of Credit Facility and Notes Payable	The table below details the outstanding balances on the Company’s debt as of June 30, 2024 and December 31, 2023: June 30, December 31, Notes payable Vehicle loans 18 26 $ 18 $ 26 Current 10 13 Non-current $ 8 13

Commitments and Contingencies (

Commitments and Contingencies (Tables)	6 Months Ended
	Jun. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Concentration of Risk, by Risk Factor	The Company’s customers that accounted for 10% or more of total net sales and total accounts receivable were as follows: Net sales Accounts receivable Six Months Ended June 30, June 30, December 31, 2024 2023 Customer A 27 % 30 % 25 % 20 % Customer B 22 % 23 % 20 % 23 % Six Months Ended June 30, 2024 2023 Supplier A 22 % 20 % Supplier B 14 % 15 %

Derivative Instruments (Tables)

Derivative Instruments (Tables)	6 Months Ended
	Jun. 30, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Summary of Notional Amount and Fair Value of All Outstanding Derivative Instruments	The notional amount and fair value of all outstanding derivative instruments in the condensed consolidated balance sheets consist of the following at: June 30, 2024 Derivatives not designated as Notional Fair Balance Sheet Location Assets Foreign currency exchange contracts Receive USD/pay EUR $ 4,279 $ 55 Derivative assets Receive USD/pay CAD 6,097 85 Derivative assets Liabilities Foreign currency exchange contracts Receive BRL/sell USD $ 51,459 $ (4,339) Derivative liabilities Receive THB/sell USD 18,647 (1,243) Derivative liabilities Receive USD/pay GBP 21,277 (383) Derivative liabilities December 31, 2023 Derivatives not designated as Notional Fair Balance Sheet Location Assets Foreign currency exchange contracts Receive BRL/sell USD $ 62,253 $ 3,876 Derivative assets Liabilities Foreign currency exchange contracts Receive THB/sell USD 21,971 (285) Derivative liabilities Receive USD/pay EUR 5,627 (90) Derivative liabilities Receive USD/pay GBP 23,512 (749) Derivative liabilities Receive USD/pay CAD 7,666 (89) Derivative liabilities
Summary of Realized and Unrealized Gains and Losses of the Derivative Instruments	The amount and location of realized and unrealized gains and losses of the derivative instruments in the condensed consolidated statements of operations for the three and six months ended June 30, 2024 and 2023 are as follows: Three Months Ended June 30, 2024 2023 Unrealized gain/(loss) on derivative instruments $ (5,963) $ 988 Location Unrealized gain/(loss) Unrealized gain/(loss) Foreign currency gain / (loss) $ 188 $ 1,572 Location Foreign currency Foreign currency Six Months Ended June 30, 2024 2023 Unrealized gain/(loss) on derivative instruments $ (8,488) $ 2,201 Location Unrealized gain/(loss) Unrealized gain/(loss) Foreign currency gain / (loss) $ 795 $ 2,643 Location Foreign currency Foreign currency

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2024
Fair Value Disclosures [Abstract]
Summary of Assets and Liabilities that are Measured at Fair Value on a Recurring Basis	The Company’s fair value hierarchy for those assets (liabilities) measured at fair value on a recurring basis at June 30, 2024 and December 31, 2023, is as follows: Level 1 Level 2 Level 3 Total Forward Currency June 30, 2024 $ — $ (5,825) $ — $ (5,825) December 31, 2023 $ — $ 2,663 $ — $ 2,663

Earnings Per Share (Tables)

Earnings Per Share (Tables)	6 Months Ended
	Jun. 30, 2024
Earnings Per Share [Abstract]
Summary of Basic and Diluted Earnings Per Share	Basic and diluted earnings per share were calculated as follows: Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Numerator: Net income $ 19,093 $ 17,987 $ 33,331 $ 24,692 Denominator: Weighted-average number of common shares used in earnings per share—basic 56,705,220 56,325,013 56,647,393 56,186,727 Effect of conversion of stock options 2,529,991 2,529,050 2,343,528 1,916,775 Weighted-average number of common shares used in earnings per share—diluted 59,235,211 58,854,063 58,990,921 58,103,502 Earnings per share—basic $ 0.34 $ 0.32 $ 0.59 $ 0.44 Earnings per share—diluted $ 0.32 $ 0.31 $ 0.57 $ 0.42
Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive securities, prior to the use of the treasury stock method, have been excluded from the computation of diluted weighted-average number of common shares outstanding, as they would be anti-dilutive: Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Options to purchase common stock and RSUs 207,168 54,008 254,490 560,721

Segment Reporting (Tables)

Segment Reporting (Tables)	6 Months Ended
	Jun. 30, 2024
Segment Reporting [Abstract]
Schedule of Segment Reporting Information by Segment	Information about the Company’s operations by operating segment as of the three and six months ended June 30, 2024 and 2023 is as follows: Three Months Ended June 30, Six Months Ended June 30, 2024 2023 2024 2023 Net sales $ 144,116 $ 139,645 $ 255,814 $ 249,404 Americas 124,502 121,263 220,593 218,035 International 19,614 18,382 35,221 31,369 Gross profit $ 58,737 $ 51,094 $ 105,914 $ 84,755 Americas 52,208 45,109 93,080 74,258 International 6,529 5,985 12,834 10,497 As of June 30, As of December 31, 2024 2023 Total segment assets $ 323,036 $ 285,682 Americas 225,790 209,984 International 97,246 75,698
Reconciliation of Gross Profit to Income (Loss) Before Income Taxes	Three Months Ended June 30, Six Months Ended June 30, Reconciliation 2024 2023 2024 2023 Total gross profit $ 58,737 $ 51,094 $ 105,914 $ 84,755 Less: Selling, general, and administrative expenses 28,756 30,249 56,974 57,206 Income (loss) from operations $ 29,981 $ 20,845 $ 48,940 $ 27,549 Less: Unrealized gain/(loss) on derivative instruments (5,963) 988 (8,488) 2,201 Foreign currency gain/(loss) (136) 170 (78) 781 Interest income 1,627 268 3,150 281 Interest expense — (15) — (30) Income before income taxes $ 25,509 $ 22,256 $ 43,524 $ 30,782
Revenue from External Customers by Geographic Areas	The following table provides information related to the Company’s net sales by country, which is presented on the basis of the location that revenue from customers is recorded: Six Months Ended June 30, 2024 2023 United States $ 205,561 $ 204,152 United Kingdom 25,862 21,622 All other countries(1) 24,391 23,631 Net sales $ 255,814 $ 249,404 ___________ (1) No individual country is greater than 10% of total net sales for the six months ended June 30, 2024 and 2023.
Long-lived Assets by Geographic Areas	The following table provides information related to the Company’s property and equipment, net by country: June 30, December 31, United States $ 857 $ 729 Singapore 1,076 1,081 All other countries(1) 298 326 Property and equipment, net $ 2,231 $ 2,136 ___________ (1) No individual country is greater than 10% of total property and equipment, net as of June 30, 2024 and December 31, 2023.

Nature of Business and Basis _2

Nature of Business and Basis of Presentation (Details) - Subsidiaries	6 Months Ended
	Jun. 30, 2024 subsidiary
Subsidiaries Owned [Line Items]
Number of subsidiaries	10
Asia
Subsidiaries Owned [Line Items]
Number of subsidiaries	4
North America
Subsidiaries Owned [Line Items]
Number of subsidiaries	4

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details) - Customer Concentration Risk - Two Customers	6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Net sales
Concentration Risk [Line Items]
Concentration risk, percentage	49%	53%
Accounts receivable
Concentration Risk [Line Items]
Concentration risk, percentage	45%		43%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Allowance for Credit Loss (Details) - Accounting Standards Update 2016-13 $ in Thousands	Jan. 01, 2023 USD ($)
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit losses on accounts receivables	$ 2,898
Allowance for credit losses on supplier advances	0
Total	2,898
As reported under ASC 326
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit losses on accounts receivables	3,552
Allowance for credit losses on supplier advances	416
Total	3,968
Impact of ASC 326 adoption
Financing Receivable, Allowance for Credit Loss [Line Items]
Allowance for credit losses on accounts receivables	654
Allowance for credit losses on supplier advances	416
Total	$ 1,070

Revenue Recognition (Details)

Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Disaggregation of Revenue [Line Items]
Revenue	$ 144,116	$ 139,645	$ 255,814	$ 249,404
Vita Coco Coconut Water
Disaggregation of Revenue [Line Items]
Revenue	112,446	107,724	191,633	186,420
Private Label
Disaggregation of Revenue [Line Items]
Revenue	27,951	29,112	57,376	56,828
Other
Disaggregation of Revenue [Line Items]
Revenue	3,719	2,809	6,805	6,156
Operating Segments | Americas
Disaggregation of Revenue [Line Items]
Revenue	124,502	121,263	220,593	218,035
Operating Segments | Americas | Vita Coco Coconut Water
Disaggregation of Revenue [Line Items]
Revenue	98,494	95,004	168,016	164,142
Operating Segments | Americas | Private Label
Disaggregation of Revenue [Line Items]
Revenue	23,135	24,059	47,408	49,109
Operating Segments | Americas | Other
Disaggregation of Revenue [Line Items]
Revenue	2,873	2,200	5,169	4,784
Operating Segments | International
Disaggregation of Revenue [Line Items]
Revenue	19,614	18,382	35,221	31,369
Operating Segments | International | Vita Coco Coconut Water
Disaggregation of Revenue [Line Items]
Revenue	13,952	12,720	23,617	22,278
Operating Segments | International | Private Label
Disaggregation of Revenue [Line Items]
Revenue	4,816	5,053	9,968	7,719
Operating Segments | International | Other
Disaggregation of Revenue [Line Items]
Revenue	$ 846	$ 609	$ 1,636	$ 1,372

Inventory (Details)

Inventory (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials and packaging	$ 3,130	$ 3,360
Finished goods	42,327	47,397
Inventory	$ 45,457	$ 50,757

Goodwill - Summary of Goodwill

Goodwill - Summary of Goodwill (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 7,791	$ 7,791

Debt - Summary of Credit Facili

Debt - Summary of Credit Facility and Notes Payable (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Schedule Of Line Of Credit Facilities And Notes Payable [Line Items]
Notes payable	$ 18	$ 26
Current	10	13
Non-current	8	13
Vehicle loans
Schedule Of Line Of Credit Facilities And Notes Payable [Line Items]
Notes payable	$ 18	$ 26

Debt - Additional Information (

Debt - Additional Information (Details) - USD ($)	1 Months Ended		3 Months Ended		6 Months Ended
	Dec. 31, 2022	May 31, 2020	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Notes Payable, Other Payables | Vehicle loans
Debt Instrument [Line Items]
Long-term Debt			$ 100,000		$ 100,000
Notes Payable, Other Payables | Minimum | Vehicle loans
Debt Instrument [Line Items]
Interest rate on vehicle loans			4.56%		4.56%
Notes Payable, Other Payables | Maximum | Vehicle loans
Debt Instrument [Line Items]
Interest rate on vehicle loans			5.68%		5.68%
2020 Credit facility
Debt Instrument [Line Items]
Interest expense					$ 0	$ 0
Line of credit facility, unused commitment fee			$ 15,000	$ 15,000	30,000	$ 30,000
2020 Credit facility | Line of Credit
Debt Instrument [Line Items]
Debt instrument, term		5 years
Line of credit facility, maximum borrowing capacity		$ 60,000,000
Long-term line of credit			0		0		$ 0
Line of credit facility, remaining borrowing capacity			$ 60,000,000		$ 60,000,000		$ 60,000,000
2020 Credit facility | Line of Credit | Minimum
Debt Instrument [Line Items]
Unused capacity, commitment fee percentage	0.10%
2020 Credit facility | Line of Credit | Maximum
Debt Instrument [Line Items]
Unused capacity, commitment fee percentage	0.20%
2020 Credit facility | Line of Credit | Secured Overnight Financing Rate (SOFR) | Minimum
Debt Instrument [Line Items]
Basis spread on variable rate	1%
2020 Credit facility | Line of Credit | Secured Overnight Financing Rate (SOFR) | Maximum
Debt Instrument [Line Items]
Basis spread on variable rate	1.75%

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Details) - USD ($)		1 Months Ended	3 Months Ended
	Mar. 31, 2024	Oct. 31, 2021	Mar. 31, 2023	Jun. 30, 2024	Dec. 31, 2023
Concentration Risk [Line Items]
Estimated litigation liability				$ 0	$ 0
Restricted Stock
Concentration Risk [Line Items]
Granted RSUs (in shares)		200,000
One customer
Concentration Risk [Line Items]
Vested (in shares)	100,000		100,000

Commitments and Contingencies_2

Commitments and Contingencies - Schedule of Concentration of Risk, by Risk Factor (Details)	6 Months Ended		12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Supplier A | Supplier Concentration Risk | Cost of Goods and Service, Product and Service
Concentration Risk [Line Items]
Concentration risk, percentage	22%	20%
Supplier B | Supplier Concentration Risk | Cost of Goods and Service, Product and Service
Concentration Risk [Line Items]
Concentration risk, percentage	14%	15%
Customer A | Customer Concentration Risk | Net sales
Concentration Risk [Line Items]
Concentration risk, percentage	27%	30%
Customer A | Customer Concentration Risk | Accounts receivable
Concentration Risk [Line Items]
Concentration risk, percentage	25%		20%
Customer B | Customer Concentration Risk | Net sales
Concentration Risk [Line Items]
Concentration risk, percentage	22%	23%
Customer B | Customer Concentration Risk | Accounts receivable
Concentration Risk [Line Items]
Concentration risk, percentage	20%		23%

Derivative Instruments - Summar

Derivative Instruments - Summary of Notional Amount and Fair Value of All Outstanding Derivative Instruments (Details) - Not Designated as Hedging Instrument - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Receive USD/pay EUR
Derivatives, Fair Value [Line Items]
Derivative asset, notional amount	$ 4,279
Derivative asset, fair value	55
Derivative liability, notional amount		$ 5,627
Derivative liability, fair value		(90)
Receive USD/pay CAD
Derivatives, Fair Value [Line Items]
Derivative asset, notional amount	6,097
Derivative asset, fair value	85
Derivative liability, notional amount		7,666
Derivative liability, fair value		(89)
Receive BRL/sell USD
Derivatives, Fair Value [Line Items]
Derivative asset, notional amount		62,253
Derivative asset, fair value		3,876
Derivative liability, notional amount	51,459
Derivative liability, fair value	(4,339)
Receive THB/sell USD
Derivatives, Fair Value [Line Items]
Derivative liability, notional amount	18,647	21,971
Derivative liability, fair value	(1,243)	(285)
Receive USD/pay GBP
Derivatives, Fair Value [Line Items]
Derivative liability, notional amount	21,277	23,512
Derivative liability, fair value	$ (383)	$ (749)

Derivative Instruments - Summ_2

Derivative Instruments - Summary of Realized and Unrealized Gains and Losses of the Derivative Instruments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Derivatives, Fair Value [Line Items]
Unrealized gain/(loss) on derivative instruments	$ (5,963)	$ 988	$ (8,488)	$ 2,201
Unrealized gain/(loss) on derivative instruments
Derivatives, Fair Value [Line Items]
Unrealized gain/(loss) on derivative instruments	(5,963)	988	(8,488)	2,201
Foreign currency gain / (loss)
Derivatives, Fair Value [Line Items]
Foreign currency gain / (loss)	$ 188	$ 1,572	$ 795	$ 2,643

Fair Value Measurements (Detail

Fair Value Measurements (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities measured at fair value	$ (5,825)
Assets measured at fair value		$ 2,663
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets measured at fair value	0	0
Level 2 | Forward Currency Swaps/Contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities measured at fair value	(5,825)
Assets measured at fair value		2,663
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Liabilities measured at fair value	$ 0
Assets measured at fair value		$ 0

Shareholders' Equity (Details)

Shareholders' Equity (Details) $ / shares in Units, $ in Thousands					1 Months Ended	3 Months Ended				6 Months Ended		12 Months Ended
	Mar. 31, 2024	May 23, 2023 $ / shares shares	Mar. 31, 2023	Oct. 01, 2021 shares	Oct. 31, 2021 USD ($) $ / shares shares	Jun. 30, 2024 USD ($) shares	Mar. 31, 2024 shares	Jun. 30, 2023 USD ($) shares	Mar. 31, 2023 shares	Jun. 30, 2024 USD ($) vote shares	Jun. 30, 2023 USD ($) shares	Dec. 31, 2023 USD ($) shares	Oct. 30, 2023 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of votes per share of common stock | vote										1
Treasury stock (in shares)						6,627,744				6,627,744		6,236,200
Stock repurchase program, authorized amount | $						$ 29,992				$ 29,992			$ 40,000
Payments for repurchase of common stock | $										9,235	$ 0	$ 773
Stock-based compensation expense | $						2,399		$ 1,951		4,357	3,248
Stock-based sales incentive | $						$ 0		$ 151		$ 151	1,016
Public Stock Offering
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, number of shares issued in transaction (in shares)		5,000,000
Sale of stock, price per share (in dollars per share) | $ / shares		$ 23
Payments of stock issuance costs | $											$ 856
Over-Allotment Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, number of shares issued in transaction (in shares)		750,000
Over-allotment option period		30 days
Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock repurchased during period (in shares)						0				391,544		30,000
Exercise of stock awards (in shares)						91,376	176,284	230,857	185,783
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)						18,788		28,390		181,112	147,649
Aggregate intrinsic value, nonvested | $					$ 3,000
Granted (in dollars per share) | $ / shares					$ 15
Granted RSUs (in shares)					200,000
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate grant date fair value | $										$ 8,348
Service-Based Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise of stock awards (in shares)						72,588		202,467		86,548	268,990
Granted RSUs (in shares)										259,221
Performance-Based Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted RSUs (in shares)										58,365
Service-based Stock Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options granted (in shares)										168,076
2021 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common shares reserved for future issuance (in shares)						3,219,779				3,219,779		3,124,326
Percentage of outstanding stock maximum				2%
2021 Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common shares reserved for future issuance (in shares)				3,431,312
2014 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of outstanding stock maximum										8%
Share based compensation arrangement by share based payment award, Award vesting period										10 years
2014 Plan | Tranche One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vesting of award under share-based payment arrangement			50%
2014 Plan | Tranche Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of vesting of award under share-based payment arrangement	50%

Income Taxes (Details)

Income Taxes (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income tax expense	$ 6,416,000	$ 4,269,000	$ 10,193,000	$ 6,090,000
Unrecognized tax benefits	$ 106,000		$ 106,000		$ 106,000

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Numerator:
Net income	$ 19,093	$ 17,987	$ 33,331	$ 24,692
Denominator:
Weighted-average number of common shares used in earnings per share - basic (in shares)	56,705,220	56,325,013	56,647,393	56,186,727
Effect of conversion of stock options and RSUs (in shares)	2,529,991	2,529,050	2,343,528	1,916,775
Weighted-average number of common shares used in earnings per share - diluted (in shares)	59,235,211	58,854,063	58,990,921	58,103,502
Earnings per share - basic (in dollars per share)	$ 0.34	$ 0.32	$ 0.59	$ 0.44
Earnings per share - diluted (in dollars per share)	$ 0.32	$ 0.31	$ 0.57	$ 0.42

Earnings Per Share - Summary of

Earnings Per Share - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Share-based Payment Arrangement, Option
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Options to purchase common stock and RSUs (in shares)	207,168	54,008	254,490	560,721

Segment Reporting - Additional

Segment Reporting - Additional Information (Details)	6 Months Ended
	Jun. 30, 2024 segment
Segment Reporting [Abstract]
Number of operating segments	2
Number of reportable segments	2

Segment Reporting - Schedule of

Segment Reporting - Schedule of Segment Reporting Information by Segment (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
Segment Reporting Information [Line Items]
Net sales	$ 144,116	$ 139,645	$ 255,814	$ 249,404
Total gross profit	58,737	51,094	105,914	84,755
Total segment assets	323,036		323,036		$ 285,682
Operating Segments | Americas
Segment Reporting Information [Line Items]
Net sales	124,502	121,263	220,593	218,035
Total gross profit	52,208	45,109	93,080	74,258
Total segment assets	225,790		225,790		209,984
Operating Segments | International
Segment Reporting Information [Line Items]
Net sales	19,614	18,382	35,221	31,369
Total gross profit	6,529	$ 5,985	12,834	$ 10,497
Total segment assets	$ 97,246		$ 97,246		$ 75,698

Segment Reporting - Reconciliat

Segment Reporting - Reconciliation of Gross Profit to Income (Loss) Before Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Segment Reporting [Abstract]
Total gross profit	$ 58,737	$ 51,094	$ 105,914	$ 84,755
Selling, general, and administrative expenses	28,756	30,249	56,974	57,206
Income (loss) from operations	29,981	20,845	48,940	27,549
Unrealized gain/(loss) on derivative instruments	(5,963)	988	(8,488)	2,201
Foreign currency gain/(loss)	(136)	170	(78)	781
Interest income	1,627	268	3,150	281
Interest expense	0	(15)	0	(30)
Income before income taxes	$ 25,509	$ 22,256	$ 43,524	$ 30,782

Segment Reporting - Revenue fro

Segment Reporting - Revenue from External Customers by Geographic Areas (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 144,116	$ 139,645	$ 255,814	$ 249,404
United States | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales			205,561	204,152
United Kingdom | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales			25,862	21,622
All other countries | Operating Segments
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales			$ 24,391	$ 23,631

Segment Reporting - Long Lived

Segment Reporting - Long Lived Assets by Geographic Areas (Details) - USD ($) $ in Thousands	Jun. 30, 2024	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	$ 2,231	$ 2,136
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	857	729
Singapore
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	1,076	1,081
All other countries
Revenues from External Customers and Long-Lived Assets [Line Items]
Property and equipment, net	$ 298	$ 326

Related-Party Transactions (Det

Related-Party Transactions (Details) $ in Thousands	1 Months Ended		12 Months Ended
	Nov. 30, 2023 USD ($)	May 31, 2023 USD ($)	Dec. 31, 2023 offering
Related Party Transactions [Abstract]
Number of secondary offerings | offering			2
Expenses incurred, reimbursement waived | $	$ 324	$ 140